RxDoctor Payments Data

Michael Elliott, PA

Medical · Wake Village, TXNPI 1306312822

Payments from drug & device makers

$2,301in general payments, 2019–2025

Across 165 payments — averaging $13.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$718
  • Lilly USA, LLC$311
  • Novo Nordisk$267
  • Novartis$254
  • Pfizer$233
  • Phathom Pharmaceuticals, Inc.$87
  • plus $430 from 11 others

What the payments were for

  • Food & beverage$2,28299%
  • Other$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,301 in reported general payments places this provider in the 70th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Medicare billing

Part B allowed, 2024
$77,874
Medicare patients
439
Services billed
2,720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide29$30,791
VraylarCariprazine Hcl12$20,141
OzempicSemaglutide21$19,540
JardianceEmpagliflozin25$17,727
FarxigaDapagliflozin Propanediol14$16,796
RybelsusSemaglutide11$12,612
Albuterol Sulfate HfaAlbuterol Sulfate39$969
Losartan Potassium85$882
Pantoprazole Sodium78$881
Omeprazole67$840
Gabapentin64$822
Fluticasone Propionate59$763
Azithromycin106$754
Metoprolol Succinate63$678
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$644

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$267$32,15232 claims
Lilly USA, LLCMounjaro$311$30,79129 claims
AbbVieVraylar$718$20,14112 claims
AstraZenecaFarxiga$78$16,79614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,490 medical providers in Texas.

Other medical in Wake Village

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →